Aspira Women’s Health (AWHL) OKs stock plan share increase and auditor
Rhea-AI Filing Summary
Aspira Women’s Health Inc. reported the results of its 2026 annual stockholder meeting. Of 43,500,411 common shares entitled to vote as of the record date, 27,144,522 shares were represented, a quorum of 62.40%.
Stockholders elected all six director nominees for one‑year terms and approved, on an advisory basis, the compensation of the company’s named executive officers. They also approved an amendment to the 2019 Stock Incentive Plan to add 5,000,000 shares, bringing the total shares authorized under the plan to 9,532,818.
In addition, stockholders ratified the selection of BDO USA, P.C. as the independent registered public accounting firm for the year ending December 31, 2026.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares entitled to vote: 43,500,411 shares
Shares represented at meeting: 27,144,522 shares
Quorum percentage: 62.40%
+3 more
6 metrics
Shares entitled to vote
43,500,411 shares
Common stock issued, outstanding and entitled to vote on record date
Shares represented at meeting
27,144,522 shares
Shares present in person or by proxy (62.40% quorum)
Quorum percentage
62.40%
Portion of entitled shares present at 2026 annual meeting
Plan share increase
5,000,000 shares
Additional shares authorized under 2019 Stock Incentive Plan
Total plan authorization
9,532,818 shares
Total shares authorized under 2019 Stock Incentive Plan after amendment
Auditor ratification for votes
22,810,174 votes
Votes cast for ratifying BDO USA, P.C. for year ending Dec. 31, 2026
Key Terms
broker non-votes, advisory basis, 2019 Stock Incentive Plan, independent registered public accounting firm
4 terms
broker non-votes financial
"ABSTENTIONS | | | BROKER NON-VOTES |"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
advisory basis financial
"stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers"
2019 Stock Incentive Plan financial
"approved an amendment to the Company’s 2019 Stock Incentive Plan (the “2019 Plan”)"
independent registered public accounting firm financial
"ratified the selection of BDO USA, P.C. as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Aspira Women’s Health (AWHL) stockholders vote on at the 2026 annual meeting?
Stockholders voted on electing six directors, approving executive compensation on an advisory basis, amending the 2019 Stock Incentive Plan, and ratifying BDO USA, P.C. as the independent registered public accounting firm for 2026.
Was the Aspira Women’s Health (AWHL) 2019 Stock Incentive Plan amendment approved?
Yes, stockholders approved increasing the shares authorized under the 2019 Stock Incentive Plan by 5,000,000, so that a total of 9,532,818 shares of common stock are authorized to be granted under the plan going forward.
Did Aspira Women’s Health (AWHL) stockholders approve executive compensation?
Yes, in a non-binding advisory vote, stockholders approved the compensation of the company’s named executive officers as described in the April 20, 2026 definitive proxy statement filed with the Securities and Exchange Commission.
Which audit firm did Aspira Women’s Health (AWHL) stockholders ratify for 2026?
Stockholders ratified the selection of BDO USA, P.C. as Aspira Women’s Health Inc.’s independent registered public accounting firm for the year ending December 31, 2026, confirming the firm’s role in auditing that fiscal year’s financial statements.
Were all Aspira Women’s Health (AWHL) director nominees elected?
Yes, all six director nominees, including Ellen Beausang and Jane Pine Wood, were elected to one-year terms expiring at the next annual meeting, each receiving more votes cast for than against their election.